NeoGenomics

NeoGenomics

Yahoo Finance • 29 days ago

Stocks making the biggest moves midday: Goldman Sachs, Webull, Worthington Steel, Micron & more

Check out the companies making the biggest moves midday: Banks — The group fell, with pressure coming from longer-dated Treasury yields rising to levels not seen in 24 years. Shares of Citigroup , Wells Fargo and Goldman Sachs fell nearly... Full story

Yahoo Finance • 29 days ago

Stocks making the biggest moves premarket: Constellation Brands, Flutter Entertainment, Neogen & more

Check out the companies making headlines before the bell: Neogen Corp – The food safety company jumped 11% after raising its fiscal year guidance. Neogen sees revenue ranging between $885 million and $890 million, versus its earlier call f... Full story

Yahoo Finance • 30 days ago

Did Strong Q3 Outlook and New CEO Plan Just Shift NeoGenomics' (NEO) Investment Narrative?

NeoGenomics, Inc. recently amended its bylaws to expand its Board to up to eleven directors, issued preliminary third-quarter 2026 revenue guidance of about US$209 million with very strong next-generation sequencing growth, and outlined pl... Full story

Yahoo Finance • 30 days ago

Stryker, Neogenomics Announce CEO Transitions; But One Stock Dives

Stryker and Neogenomics stocks diverged Tuesday after the medtech companies announced their chief executives would soon step down. Continue Reading... Full story

Yahoo Finance • last month

3 Healthcare Stocks We’re Skeptical Of

3 Healthcare Stocks We're Skeptical Of Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only ris... Full story

Yahoo Finance • last month

Is Neo Performance Materials (TSX:NEO) Undervalued As Its European Magnet Plant Enters Commercial Production?

Commercial production milestone and why it matters for Neo Performance Materials Neo Performance Materials (TSX:NEO) has moved its European permanent magnet plant into commercial production, now shipping rare earth sintered magnets to a T... Full story

Yahoo Finance • 2 months ago

Which Is the Better Healthcare ETF: Fidelity's Low-Cost FHLC or First Trust's High-Conviction FBT?

Fidelity MSCI Health Care Index ETF (NYSEMKT:FHLC) offers broad healthcare exposure at a fraction of the cost, while First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT:FBT) provides an aggressive, concentrated focus on biotechnology i... Full story

Yahoo Finance • 3 months ago

3 Healthcare Stocks with Questionable Fundamentals

3 Healthcare Stocks with Questionable Fundamentals From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial p... Full story

Yahoo Finance • 3 months ago

NeoGenomics anticipates $802M-$806M 2026 revenue as it targets mid-20% NGS growth and adjusts pharma expectations

Earnings Call Insights: NeoGenomics (NEO) Q2 2026 MANAGEMENT VIEW * "We're raising guidance because of these results as well as the underlying clinical strength we're seeing in the back half of this year." (CEO Anthony Zook) * "Tota... Full story

Yahoo Finance • 3 months ago

Which Is the Better Healthcare ETF: First Trust's High-Conviction FBT or Vanguard's Low-Cost VHT?

The First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT:FBT) provides concentrated, high-conviction exposure to biotechnology firms, while the Vanguard Health Care ETF (NYSEMKT:VHT) offers a cheaper, diversified basket across the entir... Full story

Yahoo Finance • 4 months ago

Which Healthcare ETF Is the Better Buy: iShares' Global IXJ or First Trust's Biotech FBT?

Key Points iShares Global Healthcare ETF provides broad exposure to 110 global stocks while First Trust NYSE Arca Biotechnology Index Fund concentrates on 30 biotech positions. iShares Global Healthcare ETF carries a lower expense ratio... Full story

Yahoo Finance • 4 months ago

Which Is the Better Healthcare ETF, First Trust's Biotech-Focused FBT or State Street's Broader XLV?

Investors choosing between the State Street Health Care Select Sector SPDR ETF (NYSEMKT:XLV) and First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT:FBT) must weigh XLV's broad healthcare diversification and low cost against FBT's conc... Full story

Yahoo Finance • 4 months ago

Is NeoGenomics (NEO) Undervalued After Its FDA Approved PTEN Test Launch?

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. NeoGenomics (NEO) drew fresh attention after announcing PTEN IHC C... Full story

Yahoo Finance • 4 months ago

Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance?

Comparing First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT:FBT) and iShares Biotechnology ETF (NASDAQ:IBB) reveals a choice between FBT's highly concentrated portfolio and IBB's broader, market-cap-weighted industry exposure. Both... Full story

Yahoo Finance • 4 months ago

NeoGenomics (NEO) Stock Trades Up, Here Is Why

NeoGenomics (NEO) Stock Trades Up, Here Is Why What Happened? Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) jumped 3.4% in the afternoon session after the company announced the launch of the first FDA-approved... Full story

Yahoo Finance • 4 months ago

NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer

Available within NEO PanTracer™ Pro for prostate cancer and as a standalone test, PTEN IHC CDx identifies patients who may be eligible for TRUQAP® FORT MYERS, Fla., July 09, 2026--(BUSINESS WIRE)--NeoGenomics, Inc. (NASDAQ: NEO), a leadin... Full story

Yahoo Finance • 5 months ago

1 Unprofitable Stock for Long-Term Investors and 2 Facing Headwinds

1 Unprofitable Stock for Long-Term Investors and 2 Facing Headwinds Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. Unprofitable compan... Full story

Yahoo Finance • 5 months ago

NeoGenomics launches $275M convertible notes offering due 2032

* NeoGenomics (NEO [https://seekingalpha.com/symbol/NEO]) announced [https://seekingalpha.com/pr/20552127-neogenomics-announces-proposed-offering-of-275-million-convertible-senior-notes] a private offering of $275M in convertible senior... Full story

Yahoo Finance • 6 months ago

Neo Partners with Greenland Mines to Advance Sarfartoq Rare Earth Project

TORONTO, May 20, 2026 (GLOBE NEWSWIRE) -- Neo Performance Materials Inc. (“Neo” or the “Company”) (TSX: NEO; OTCQX: NOPMF) today announced that its wholly-owned subsidiary, Neo North Star Holdings Inc. (“NNSH”), together with the other s... Full story

Yahoo Finance • 6 months ago

Neo Performance Materials Q1 Earnings Call Highlights

Key Points Interested in Neo Performance Materials Inc.? Here are five stocks we like better. Neo Performance Materials raised its full-year 2026 adjusted EBITDA guidance to $100 million-$110 million from $75 million-$80 million after pos... Full story